SCHEMBL7142125

SCHEMBL7142125

N=C(N)Nc1nc(C(=O)O)c(-c2ccccc2)s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XIAP P98170 5/20 0.47
ALDH1A1 P00352 5/20 0.45
KDM4E B2RXH2 2/20 0.45
HSD17B10 Q99714 2/20 0.45
HPGD P15428 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
GAA P10253 2/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
MAPT P10636 2/20 0.42
ATAD2 Q6PL18 1/20 0.42
PTGS2 P35354 1/20 0.42
RORC P51449 1/20 0.40
ADORA2A P29274 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7143965 0.87 KDM4E (0.64) XIAPALDH1A1KDM4EHSD17B10HPGD
Hydrochloric Acid SCHEMBL7147755 0.81 CSNK2A1 (0.45) ALDH1A1SMN1; SMN2GAAMEN1KMT2A
SCHEMBL7146818 0.77 ADORA3 (0.56) XIAPALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL7143987 0.77 HTT (0.42) ALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL13398657 0.76 LCK (0.48) XIAPALDH1A1KDM4EHSD17B10HPGD
SCHEMBL7138733 0.76 MMP3 (0.52) KDM4ERORCIKBKB
SCHEMBL28076257 0.75 GAA (0.45) XIAPALDH1A1KDM4EHSD17B10HPGD
SCHEMBL3315703 0.74 KDM4E (0.47) ALDH1A1KDM4EHSD17B10HPGDSMN1; SMN2
SCHEMBL7142132 0.74 RAB9A (0.39) XIAPALDH1A1HSD17B10SMN1; SMN2GAA
SCHEMBL3601760 0.74 MEN1 (0.63) XIAPALDH1A1SMN1; SMN2GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0928790-B1 Thiazole derivatives HOFFMANN LA ROCHE (CH) 2003-03-05 EP disclosed
US-6344562-B1 ANTITUMOR AGENTS HOFFMANN-LA ROCHE INC. 2002-02-05 US disclosed
US-20020010316-A1 Thiazole derivatives ALIG LEO (CH) 2002-01-24 US disclosed
US-6320054-B1 INHIBIT BINDING OF ADHESIVE PROTEINS TO THE SURFACE OF DIFFERENT TYPES F CELL AND ACCORDINGLY INFLUENCE CELL-CELL AND CELL-MATRIX INTERACTIONS. HOFFMAN-LA ROCHE INC. 2001-11-20 US disclosed
US-6100282-A Thiazole derivatives HOFFMAN-LA ROCHE INC. (US) 2000-08-08 US disclosed
EP-0928790-A1 Thiazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 1999-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020010316-A1 Thiazole derivatives VCAM1, SOST, TGFB1 XIAP 3269/4885ALDH1A1 1400/4885KDM4E 4278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.